{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:59:18Z","timestamp":1789707558383,"version":"4.0.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA246592"],"award-info":[{"award-number":["R01CA246592"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,1,31]]},"DOI":"10.1038\/s41416-025-03246-4","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T14:28:06Z","timestamp":1762180086000},"page":"225-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Steroid hormone metabolites and mammographic breast density in premenopausal women"],"prefix":"10.1038","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-0947","authenticated-orcid":false,"given":"Ghazaleh","family":"Pourali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayode A.","family":"Matthew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Sik","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongliang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2759-3072","authenticated-orcid":false,"given":"Jingqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1079-2606","authenticated-orcid":false,"given":"Adetunji T.","family":"Toriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"3246_CR1","first-page":"151","volume":"4","author":"CA Lange","year":"2008","unstructured":"Lange CA, Yee D. Progesterone and breast cancer. Women\u2019s Health. 2008;4:151\u201362.","journal-title":"Women\u2019s Health"},{"key":"3246_CR2","doi-asserted-by":"publisher","first-page":"a003178","DOI":"10.1101\/cshperspect.a003178","volume":"2","author":"C Brisken","year":"2010","unstructured":"Brisken C, O\u2019Malley B. Hormone action in the mammary gland. Cold Spring Harb Perspect Biol. 2010;2:a003178\u2013a.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3246_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5468\/ogs.2013.56.3.143","volume":"56","author":"JH Yu","year":"2013","unstructured":"Yu JH, Kim MJ, Cho H, Liu HJ, Han S-J, Ahn T-G. Breast diseases during pregnancy and lactation. Obstet Gynecol Sci. 2013;56:143\u201359.","journal-title":"Obstet Gynecol Sci"},{"key":"3246_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342\u20138.","journal-title":"Nature"},{"key":"3246_CR5","doi-asserted-by":"publisher","first-page":"dju078","DOI":"10.1093\/jnci\/dju078","volume":"106","author":"A Pettersson","year":"2014","unstructured":"Pettersson A, Graff RE, Ursin G, dos Santos Silva I, McCormack V, Baglietto L, et al. Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. 2014;106:dju078.","journal-title":"J Natl Cancer Inst"},{"key":"3246_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","volume":"15","author":"VA McCormack","year":"2006","unstructured":"McCormack VA, Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15:1159\u201369.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3246_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-246","volume":"6","author":"N Eigeliene","year":"2006","unstructured":"Eigeliene N, H\u00e4rk\u00f6nen P, Erkkola R. Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures. BMC Cancer. 2006;6:246.","journal-title":"BMC Cancer"},{"key":"3246_CR8","first-page":"4559","volume":"84","author":"LJ Hofseth","year":"1999","unstructured":"Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, Haslam SZ. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab. 1999;84:4559\u201365.","journal-title":"J Clin Endocrinol Metab"},{"key":"3246_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1158\/1055-9965.EPI-17-0158","volume":"27","author":"A Howell","year":"2018","unstructured":"Howell A, Ashcroft L, Fallowfield L, Eccles DM, Eeles RA, Ward A, et al. RAZOR: a phase II open randomized trial of screening plus goserelin and raloxifene versus screening alone in premenopausal women at increased risk of breast cancer. Cancer Epidemiol, Biomark Prev. 2018;27:58\u201366.","journal-title":"Cancer Epidemiol, Biomark Prev"},{"key":"3246_CR10","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/jnci\/djr079","volume":"103","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, et al. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst. 2011;103:744\u201352.","journal-title":"J Natl Cancer Inst"},{"key":"3246_CR11","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/jnci\/dji279","volume":"97","author":"A McTiernan","year":"2005","unstructured":"McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, et al. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women\u2019s Health Initiative randomized trial. J Natl Cancer Inst. 2005;97:1366\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"3246_CR12","first-page":"653","volume":"11","author":"CM Vachon","year":"2000","unstructured":"Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000;11:653\u201362.","journal-title":"Cancer Causes Control"},{"key":"3246_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12672-017-0321-6","volume":"9","author":"KA Bertrand","year":"2018","unstructured":"Bertrand KA, Eliassen AH, Hankinson SE, Rosner BA, Tamimi RM. Circulating hormones and mammographic density in premenopausal women. Horm Cancer. 2018;9:117\u201327.","journal-title":"Horm Cancer"},{"key":"3246_CR14","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1158\/0008-5472.CAN-09-0280","volume":"69","author":"K Walker","year":"2009","unstructured":"Walker K, Fletcher O, Johnson N, Coupland B, McCormack VA, Folkerd E, et al. Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res. 2009;69:6490\u20139.","journal-title":"Cancer Res"},{"key":"3246_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1158\/1055-9965.EPI-14-0939","volume":"24","author":"S Jung","year":"2015","unstructured":"Jung S, Stanczyk FZ, Egleston BL, Snetselaar LG, Stevens VJ, Shepherd JA, et al. Endogenous sex hormones and breast density in young women. Cancer Epidemiol Biomark Prev. 2015;24:369\u201378.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3246_CR16","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/annonc\/mdt158","volume":"24","author":"JH Chen","year":"2013","unstructured":"Chen JH, Chen WP, Chan S, Yeh DC, Su MY, McLaren CE. Correlation of endogenous hormonal levels, fibroglandular tissue volume and percent density measured using 3D MRI during one menstrual cycle. Ann Oncol. 2013;24:2329\u201335.","journal-title":"Ann Oncol"},{"key":"3246_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/jnci\/77.3.617","volume":"77","author":"F Meyer","year":"1986","unstructured":"Meyer F, Brisson J, Morrison AS, Brown JB. Endogenous sex hormones, prolactin, and mammographic features of breast tissue in premenopausal women2. JNCI: J Natl Cancer Inst. 1986;77:617\u201320.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"3246_CR18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1158\/1055-9965.EPI-20-1567","volume":"30","author":"TP Ahern","year":"2021","unstructured":"Ahern TP, Sprague BL, Farina NH, Tsai E, Cuke M, Kontos D, et al. Lifestyle, behavioral, and dietary risk factors in relation to mammographic breast density in women at high risk for breast cancer. Cancer Epidemiol, Biomark Prev. 2021;30:936\u201344.","journal-title":"Cancer Epidemiol, Biomark Prev"},{"key":"3246_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01332-4","volume":"22","author":"M Gabrielson","year":"2020","unstructured":"Gabrielson M, Azam S, Hardell E, Holm M, Ubhayasekera KA, Eriksson M, et al. Hormonal determinants of mammographic density and density change. Breast Cancer Res. 2020;22:95.","journal-title":"Breast Cancer Res"},{"key":"3246_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.breast.2005.04.014","volume":"15","author":"JJ Noh","year":"2006","unstructured":"Noh JJ, Maskarinec G, Pagano I, Cheung LWK, Stanczyk FZ. Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast. 2006;15:20\u20138.","journal-title":"Breast"},{"key":"3246_CR21","first-page":"1039","volume":"20","author":"M Yong","year":"2009","unstructured":"Yong M, Atkinson C, Newton KM, Aiello Bowles EJ, Stanczyk FZ, Westerlind KC, et al. Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women. Cancer Causes Control. 2009;20:1039\u201353.","journal-title":"Cancer Causes Control"},{"key":"3246_CR22","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/sj.bjc.6600537","volume":"87","author":"NF Boyd","year":"2002","unstructured":"Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, et al. The association of breast mitogens with mammographic densities. Br J Cancer. 2002;87:876\u201382.","journal-title":"Br J Cancer"},{"key":"3246_CR23","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1158\/1055-9965.EPI-05-0558","volume":"14","author":"RM Tamimi","year":"2005","unstructured":"Tamimi RM, Hankinson SE, Colditz GA, Byrne C. Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomark Prev. 2005;14:2641\u20137.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3246_CR24","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1158\/1055-9965.EPI-19-1120","volume":"29","author":"M Gabrielson","year":"2020","unstructured":"Gabrielson M, Ubhayasekera KA, Acharya SR, Franko MA, Eriksson M, Bergquist J, et al. Inclusion of endogenous plasma dehydroepiandrosterone sulfate and mammographic density in risk prediction models for breast cancer. Cancer Epidemiol Biomark Prev. 2020;29:574\u201381.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3246_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.tjnut.2023.12.023","volume":"154","author":"KA Matthew","year":"2024","unstructured":"Matthew KA, Getz KR, Jeon MS, Luo C, Luo J, Toriola AT. Associations of vitamins and related cofactor metabolites with mammographic breast density in premenopausal women. J Nutr. 2024;154:424\u201334.","journal-title":"J Nutr"},{"key":"3246_CR26","doi-asserted-by":"publisher","DOI":"10.1289\/EHP14065","volume":"132","author":"YS Ning","year":"2024","unstructured":"Ning YS, Getz KR, Kyeyune JK, Jeon MS, Luo C, Luo J, et al. PFAS levels, early life factors, and mammographic breast density in premenopausal women. Environ Health Perspect. 2024;132:097008.","journal-title":"Environ Health Perspect"},{"key":"3246_CR27","first-page":"115","volume":"60","author":"AJ Stunkard","year":"1983","unstructured":"Stunkard AJ, S\u00f8rensen T, Schulsinger F. Use of the Danish Adoption Register for the study of obesity and thinness. Res Publ Assoc Res Nerv Ment Dis. 1983;60:115\u201320.","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"3246_CR28","first-page":"1247","volume":"25","author":"L Yochum","year":"2014","unstructured":"Yochum L, Tamimi RM, Hankinson SE. Birthweight, early life body size and adult mammographic density: a review of epidemiologic studies. Cancer Causes Control. 2014;25:1247\u201359.","journal-title":"Cancer Causes Control"},{"key":"3246_CR29","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1210\/jc.2017-01020","volume":"102","author":"T-H Collet","year":"2017","unstructured":"Collet T-H, Sonoyama T, Henning E, Keogh JM, Ingram B, Kelway S, et al. A metabolomic signature of acute caloric restriction. J Clin Endocrinol Metab. 2017;102:4486\u201395.","journal-title":"J Clin Endocrinol Metab"},{"key":"3246_CR30","volume":"4","author":"AM Evans","year":"2014","unstructured":"Evans AM, Bridgewater B, Liu Q, Mitchell M, Robinson R, Dai H, et al. High resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics. Metabolomics. 2014;4:1.","journal-title":"Metabolomics"},{"key":"3246_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-2-9","volume":"2","author":"CD DeHaven","year":"2010","unstructured":"DeHaven CD, Evans AM, Dai H, Lawton KA. Organization of GC\/MS and LC\/MS metabolomics data into chemical libraries. J Cheminformatics. 2010;2:1\u201312.","journal-title":"J Cheminformatics"},{"key":"3246_CR32","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1158\/1940-6207.CAPR-18-0199","volume":"11","author":"AT Toriola","year":"2018","unstructured":"Toriola AT, Appleton CM, Zong X, Luo J, Weilbaecher K, Tamimi RM, et al. Circulating receptor activator of nuclear factor-\u03baB (RANK), RANK ligand (RANKL), and mammographic density in premenopausal women. Cancer Prev Res (Philos). 2018;11:789\u201396.","journal-title":"Cancer Prev Res (Philos)"},{"key":"3246_CR33","unstructured":"Hastie T, Tibshirani R, Narasimhan B, Chu G. impute: impute: imputation for microarray data [Internet]. Bioconductor version: Release. 2022."},{"key":"3246_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/bioinformatics\/17.6.520","volume":"17","author":"O Troyanskaya","year":"2001","unstructured":"Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, et al. Missing value estimation methods for DNA microarrays. Bioinformatics. 2001;17:520\u20135.","journal-title":"Bioinformatics"},{"key":"3246_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118\u201327.","journal-title":"Biostatistics"},{"key":"3246_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neuroimage.2017.08.047","volume":"161","author":"J-P Fortin","year":"2017","unstructured":"Fortin J-P, Parker D, Tun\u00e7 B, Watanabe T, Elliott MA, Ruparel K, et al. Harmonization of multi-site diffusion tensor imaging data. Neuroimage. 2017;161:149\u201370.","journal-title":"Neuroimage"},{"key":"3246_CR37","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28:882\u20133.","journal-title":"Bioinformatics"},{"key":"3246_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-03047-z","volume":"24","author":"Y Yu","year":"2023","unstructured":"Yu Y, Zhang N, Mai Y, Ren L, Chen Q, Cao Z, et al. Correcting batch effects in large-scale multiomics studies using a reference-material-based ratio method. Genome Biol. 2023;24:201.","journal-title":"Genome Biol"},{"key":"3246_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S Buuren","year":"2011","unstructured":"Buuren S, Groothuis-Oudshoorn K. mice: Multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1\u201367.","journal-title":"J Stat Softw"},{"key":"3246_CR40","first-page":"665","volume":"22","author":"S Kim","year":"2015","unstructured":"Kim S. ppcor: An R package for a fast calculation to semi-partial correlation coefficients. Commun Stat Appl Methods. 2015;22:665\u201374.","journal-title":"Commun Stat Appl Methods"},{"key":"3246_CR41","doi-asserted-by":"crossref","unstructured":"Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. 1996;17.","DOI":"10.1210\/edrv-17-3-221"},{"key":"3246_CR42","unstructured":"Pregnenolone\u2014an overview|ScienceDirect Topics."},{"key":"3246_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/jn\/nxab388","volume":"152","author":"KM McClain","year":"2021","unstructured":"McClain KM, Friedenreich CM, Matthews CE, Sampson JN, Check DP, Brenner DR, et al. Body composition and metabolomics in the Alberta Physical Activity and Breast Cancer Prevention Trial. J Nutr. 2021;152:419\u201328.","journal-title":"J Nutr"},{"key":"3246_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/jcm9010245","volume":"9","author":"M Hada","year":"2020","unstructured":"Hada M, Oh H, Fan S, Falk RT, Geller B, Vacek P, et al. Relationship of serum progesterone and progesterone metabolites with mammographic breast density and terminal ductal lobular unit involution among women undergoing diagnostic breast biopsy. J Clin Med. 2020;9:245.","journal-title":"J Clin Med"},{"key":"3246_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/CEJ.0000000000000130","volume":"25","author":"A Iversen","year":"2016","unstructured":"Iversen A, Frydenberg H, Furberg A-S, Flote VG, Finstad SE, McTiernan A, et al. Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women. Eur J Cancer Prev. 2016;25:9\u201318.","journal-title":"Eur J Cancer Prev"},{"key":"3246_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0581-4","volume":"17","author":"S Jung","year":"2015","unstructured":"Jung S, Egleston BL, Chandler DW, Van Horn L, Hylton NM, Klifa CC, et al. Adolescent endogenous sex hormones and breast density in early adulthood. Breast Cancer Res. 2015;17:77.","journal-title":"Breast Cancer Res"},{"key":"3246_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","volume":"13","author":"GJ Patti","year":"2012","unstructured":"Patti GJ, Yanes O, Siuzdak G. Metabolomics: the apogee of the omics trilogy. Nat Rev Mol cell Biol. 2012;13:263\u20139.","journal-title":"Nat Rev Mol cell Biol"},{"key":"3246_CR48","first-page":"936","volume":"60","author":"JP Wiebe","year":"2000","unstructured":"Wiebe JP, Muzia D, Hu J, Szwajcer D, Hill SA, Seachrist JL. The 4-pregnene and 5\u03b1-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion1. Cancer Res. 2000;60:936\u201343.","journal-title":"Cancer Res"},{"key":"3246_CR49","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1677\/erc.1.01010","volume":"13","author":"JP Wiebe","year":"2006","unstructured":"Wiebe JP. Progesterone metabolites in breast cancer. Endocr-Relat Cancer. 2006;13:717\u201338.","journal-title":"Endocr-Relat Cancer"},{"key":"3246_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2015.01.004","volume":"149","author":"JP Wiebe","year":"2015","unstructured":"Wiebe JP, Rivas MA, Mercogliano MF, Elizalde PV, Schillaci R. Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5\u03b1-dihydroprogesterone (5\u03b1P) and can be suppressed by the 5\u03b1-reductase inhibitor, finasteride. J Steroid Biochem Mol Biol. 2015;149:27\u201334.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3246_CR51","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/wdev.35","volume":"1","author":"H Macias","year":"2012","unstructured":"Macias H, Hinck L. Mammary gland development. WIREs Dev Biol. 2012;1:533\u201357.","journal-title":"WIREs Dev Biol"},{"key":"3246_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/bcr615","volume":"5","author":"SZ Haslam","year":"2003","unstructured":"Haslam SZ, Woodward TL. Host microenvironment in breast cancer development: Epithelial-cell\u2013stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland. Breast Cancer Res. 2003;5:208.","journal-title":"Breast Cancer Res"},{"key":"3246_CR53","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature09495","volume":"468","author":"E Gonzalez-Suarez","year":"2010","unstructured":"Gonzalez-Suarez E, Jacob AP, Jones J, Miller R, Roudier-Meyer MP, Erwert R, et al. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature. 2010;468:103\u20137.","journal-title":"Nature"},{"key":"3246_CR54","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1158\/1940-6207.CAPR-18-0199","volume":"11","author":"AT Toriola","year":"2018","unstructured":"Toriola AT, Appleton CM, Zong X, Luo J, Weilbaecher K, Tamimi RM, et al. Circulating receptor activator of nuclear factor-\u03baB (RANK), RANK ligand (RANKL) and mammographic density in premenopausal women. Cancer Prev Res. 2018;11:789\u201396.","journal-title":"Cancer Prev Res"},{"key":"3246_CR55","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.18632\/oncotarget.14013","volume":"8","author":"S Kiechl","year":"2016","unstructured":"Kiechl S, Schramek D, Widschwendter M, Fourkala E-O, Zaikin A, Jones A, et al. Aberrant regulation of RANKL\/OPG in women at high risk of developing breast cancer. Oncotarget. 2016;8:3811\u201325.","journal-title":"Oncotarget"},{"key":"3246_CR56","doi-asserted-by":"publisher","first-page":"30552","DOI":"10.18632\/oncotarget.15547","volume":"8","author":"E Hilborn","year":"2017","unstructured":"Hilborn E, St\u00e5l O, Jansson A. Estrogen and androgen-converting enzymes 17\u03b2-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17\u03b2-hydroxysteroid dehydrogenase type 1, 2, and breast cancer. Oncotarget. 2017;8:30552\u201362.","journal-title":"Oncotarget"},{"key":"3246_CR57","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/jnci\/djr031","volume":"103","author":"GN Farhat","year":"2011","unstructured":"Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, et al. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst. 2011;103:562\u201370.","journal-title":"J Natl Cancer Inst"},{"key":"3246_CR58","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.steroids.2010.10.010","volume":"76","author":"MS Rothman","year":"2011","unstructured":"Rothman MS, Carlson NE, Xu M, Wang C, Swerdloff R, Lee P, et al. Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry. Steroids. 2011;76:177\u201382.","journal-title":"Steroids"},{"key":"3246_CR59","doi-asserted-by":"crossref","unstructured":"Hamidovic A, Davis J, Soumare F, Datta A, Naveed A. Trajectories of allopregnanolone and allopregnanolone to progesterone ratio across the six subphases of menstrual cycle. Biomolecules. 2023;13.","DOI":"10.3390\/biom13040652"},{"key":"3246_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2025.106796","volume":"253","author":"Y Wang","year":"2025","unstructured":"Wang Y, Davis SR, Gialouris J, Desai R, Handelsman DJ. Evaluation of reference ranges of four circulating sex steroids from dried blood spots in women aged 18-40 years. J Steroid Biochem Mol Biol. 2025;253:106796.","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03246-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:21:19Z","timestamp":1768922479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03246-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,31]]}},"alternative-id":["3246"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03246-4","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Study approval was granted by the Institutional Review Board (IRB) (20200559) of Washington University School of Medicine in St. Louis. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}